Innovate UK grant for PredictImmune’s IBD drug response test
Innovate UK has awarded PredictImmune a £100,000 grant to apply its biomarker-based technology towards the prediction of drug response in IBD.
Read More
Tag: PredictImmune
PredictSURE IBD gains CE mark, set for UK and EU launch
PredictImmune is gearing up to launch its novel prognostic test for inflammatory disease after it was awarded a CE mark.
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
